Letters Long term use of psychiatric drugs

Recommendations in debate on psychiatric drugs are insufficiently justified

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2952 (Published 02 June 2015) Cite this as: BMJ 2015;350:h2952
  1. David Tovey, editor in chief, Cochrane1,
  2. Rachel Churchill, co-ordinating editor, Cochrane Depression, Anxiety, and Neurosis Group2,
  3. Clive E Adams, co-ordinating editor, Cochrane Schizophrenia Group3,
  4. Geraldine Macdonald, co-ordinating editor, Cochrane Developmental, Psychosocial, and Learning Problems Group4
  1. 1London SW1Y 4QX, UK
  2. 2University of Bristol, Bristol, UK
  3. 3Institute of Mental Health, University of Nottingham, Nottingham, UK
  4. 4Queen’s University, Belfast, UK
  1. dtovey{at}cochrane.org

We are a group of Cochrane editors who are responsible for Cochrane reviews relating to mental health. Like our colleague, Peter Gøtzsche, we are writing in a personal capacity.1

We recognise that Peter has an important record as a renowned methodologist and researcher. However, we believe that in the head to head debate on whether psychiatric drugs cause …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe